Ignite Creation Date:
2024-10-25 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06642545
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-13
Brief Title:
Efficacy and Safety Study of Disitamab Vedotin RC148 vs Albumin-Paclitaxone Toripalimab in HR-HER2-low Breast Cancer
Sponsor:
Organization:
None